We describe a rapid enzyme immunoassay for carbamazepine with a centrifugal analyzer We undertook to adapt the carbamazepine enzyme immunoassay to the centrifugal analyzer. We wished to reduce reagent costs, yet maintain adequate sensitivity, precision, and accuracy. Also, we desired to increase analysis rate and decrease sample volume.
Monitoring antiepileptic drug concentrations is important, to help prevent seizures or drug toxicity in patients. Frequently combined with other anticonvulsant drugs, carbamazepine (Tegretol, Geigy) has been advocated for the control of partial, psychomotor, grand mal, and mixed seizures, as well as for trigeminal neuralgia. Monitoring carbamazepine in serum is especially important because of its narrow therapeutic index. Oral doses of 600 to 1200 mg of carbamazepine per day can give serum values that range from 3 to 16 mg/L. The therapeutic range of carbamazepine is considered to be 2 to 8 mgfL; toxic effects usually are seen when concentrations in serum reach 9 mg/L (1).
We undertook to adapt the carbamazepine enzyme immunoassay to the centrifugal analyzer. We wished to reduce reagent costs, yet maintain adequate sensitivity, precision, and accuracy. Also, we desired to increase analysis rate and decrease sample volume.
Materials and Methods

Apparatus
The centrifugal analyzer we used was a Rotochem IIa-36 (American Instruments Co., Silver Spring, MD 20901). This instrument is under complete computer control, with a 36-space cuvette system. Spectrophotometric precision is ±0.6 milliabsorbance (mA) units with nominal 10 nm or less bandpass and cuvette temperature control of ±0.05 #{176}C according to the manufacturer's specifications. The automatic sample and reagent dispensing device we used was a Rotofill III (American Instuments Co.), which can load a 36-place transfer disc in 3.5 mm. A Canola SX-310 programmable calculator (Canon U.S.A., Inc., Long Island, NY 11040) was used for data reduction.
Reagents
Reagents were obtained commercially (EMIP5; Syva Corp., Palo Alto, CA 94304). Reagents A and B, specific for carbamazepine, were in lyophilized form, and were prepared for use with some modifications.
They were reconstituted with 3 mL of distilled water and allowed to stand at room temperature for 8 h before further dilutions were made. Reagent A was then diluted with 9 mL of diluted buffer (see below), Reagent B with 45 mL of diluted buffer. Both reagents could be used after they had stood for 1 h at room temperature. 
Results
The amount of reagents used was initially reduced by twofold and subsequently by fourfold over the manufacturer's suggestions. Sensitivity (defined as the absorbance rate change per unit of concentration change, zA/zt per c) was reduced by about half with each twofold dilution. An eightfold reduction in reagents failed to yield adequate sensitivity. Figure 1 shows the curve for absorbance vs. time for various concentrations of carbamazepine. A nonlinear response was seen between the time of initial mixing of reagents and 45 s. A best-fit nonweighted linear-regression line is obtained with the following form: From 45 to 105 s, sensitivity was insufficient (less than 1 mA/mm per mg/L). After 500 s, absolute absorbances of higher carbamazepine concentrations approached 2.0 A, the linear spectrophotometric limit of the centrifugal analyzer. 
Precision and Recovery Studies
Precision data are shown in Table 2 . We evaluated analytical recovery by adding known amounts of carbamazepine (the pure drug, obtained from Geigy Pharmaceutical Co., Summit, NJ 07901) dissolved in water/methanol (1/1) to a carbamazepine-free serum pool; the results are shown in Table 3 . In addition, carbamazepine standard materials obtained commercially (Syva Corp.) were measured by our method. We could account for an average 96% of the added drug for a series of carbamazepmne concentrations ranging from 2 to 12 mg/L.
Correlation
Studies
Our centrifugal analyzer method was compared to a "high-pressure" liquid chromatographic procedure used with a modified Kobra et al. method (2) . The correlation data for 24 patients' samples are seen in Figure 3 .
In addition, we compared our method to a gas-liquid by lysing erythrocytes with distilled water, were added to patients' sera with known carbamazepine concentrations and the assay results are shown in Table 4 .
Lipemic, uremic (serum urea nitrogen, 550 mg/L) and icteric (total bilirubin, 58 mg/L) sera did not interfere with our assay.Also,protein in concentrations as high as 9.0 mg/L did not detectably interfere. These studies were performed by mixing pooled patients' sera containing known concentrations of carbamazepine, urea nitrogen, total bilirubin, and protein with carbamazepine-free serum containing excessive concentrations of the interfering substance. Specimens containing carbamazepine stored at 4 #{176}C for three months showed no significant change in concentration as measured by our method.
Discussion
The EMIT method adapted to a centrifugal analyzer has several advantages. Much less sample, 10 ML, is used in comparison to the larger volumes required for gas-chromatographic techniques. In addition, our method does not suffer from the poor precision seen in some gas-chromatographic methods, originating from unstable thermal decomposition of carbamazepine to iminostilbene (1) . Also, at the present time, there is no reliable internal standard for carbamazepine in gas-chromatographic methods. The enzyme immunoassay technique requires no sample preparation, unlike other conventional methods, and up to 150 samples can be assayed per hour. The enzyme immunoassay technique avoids the use of radioactive labels of radioimmunoassay methods. By adapting the EMIT carbamazepine assay from the semi-automatic spectrophotometers to the centrifugal analyzer, reagent costs were reduced fourfold. Precision and recovery compared very well to that with "high-pressure" chromatography and gas-liquid chromotography.
We use a multi-point kinetic rate program with appropriate linearity checks on the obtained absorbance measurements.
In this analysis nine absorbance readings are made instead of the two readings in the more conventional methods, which should give a better statistical representation of the absorbance rates. Recently, the Syva Corporation has modified EMIT reagents A and B, allowing them to detect a wider concentration range of carbamazepine, 2-20 mg/L. We found a 20% decrease in sensitivity when we used these new reagents, but this did not seriously affect our assay.
The EMIT assay adapted to the centrifugal analyzer does have some disadvantages.
Only one drug can be analyzed at a time, but the potential sample throughput more than compensates for this inconvenience.
Hemolysis definitely suppresses carbamazepine concentrations obtained by the enzyme multiple immunoassay technique, a finding similar to that of Finley et al., who reported similar interference patterns CLIN. CHEM. 25/2. 298-300 (1979) when adapting phenytoin and phenobarbital to a centrifugal analyzer (4 
